Reportage in a Chinese medicine practice in Lyon, France Acupuncture session. (Photo by: ... [+] BSIP/Universal Images Group via Getty Images)
Sometimes I'm not sure whether the best response to pseudoscience is to ignore it, or to patiently try to explain why it's wrong, or to get mad.
This week I'm mad.
My anger and frustration was triggered bya tweetfrom Memorial Sloan-Kettering's Integrative Medicine account, shown here:
Image captured by the author
For those who don't know,Memorial Sloan-Kettering Cancer Centeris one of the world's leading cancer centers, both for treatment and research. If you are diagnosed with cancer, MSK is one of the best places to go.
But not everything at MSK is world class. Unfortunately, they have an"integrative medicine"center that offers a mixture of therapies ranging from helpful to benign to useless. One of their biggest activities is acupuncture, which they claim offers a wide range of benefits to cancer patients.
The MSK tweet shown here was boasting abouta new, $3.7 million studyfunded by NIH to study the effect of acupuncture on pain that cancer patients experience from chemotherapy and bone-marrow transplants.
Here's why I'm mad: cancer patients are extremely vulnerable, often suffering the most frightening and difficult experience of their lives. They are completely dependent on medical experts to help them. When a place like MSK suggests a treatment, patients take it very seriouslyas they should. But they really have no choice: a cancer patient cannot easily look for a second opinion, or switch hospitals or doctors. Even if they have the money (and cancer treatment is extremely expensive), switching hospitals might involve a long interruption with no treatment, during which they could die, and it might also involve traveling far from their home.
Offering these patients ineffective treatments based on pseudoscienceand make no mistake, that's what acupuncture isis immoral. Now, I strongly suspect that the MSK's "integrative medicine" doctors sincerely believe that acupuncture works. Their director, Jun Mao, is clearly a true believer, as explained inthis profile of himon the MSK website. But that doesn't make it okay.
I've written about acupuncture many times before (here,here,here, andhere, for example), but let me explain afresh why it is nonsense.
Acupuncture is based on a pre-scientific notion, invented long before humans understood physiology, chemistry, neurology, or even basic physics, which posits that a mysterious life force, called "qi," flows through the body on energy lines called meridians. As explainedin this article by MSK's Jun Mao:
"According to traditional Chinese medicine ... interruption or obstruction of qi was believed to make one vulnerable to illness. The insertion of needles at specific meridian acupoints was thought to regulate the flow of qi, thus producing therapeutic benefit."
Today we know that none of this exists. There is no qi, and there are no meridians. In that same article, Jun Mao continued by admitting that
"the ideas of qi and meridians are inconsistent with the modern understanding of human anatomy and physiology."
And yet this is what they offer to patients at MSK.
Just to be certain, I readone of the latest studies from MSK, published early this year, which claims to show that acupuncture relieves nausea, drowsiness, and lack of appetite in multiple myeloma patients who were going through stem cell transplants.
It's a mess: totally unconvincing, and a textbook case of p-hacking (ordata dredging). The paper describes a very small study, with just 60 patients total, in which they measured literally dozens of possible outcomes: overall symptom score at 3 different time points, a different score at 3 time points, each of 13 symptoms individually, and more. I counted 24 different p-values, most of them not even close to significant, but they fixated on the 3 that reached statistical significance. The two groups of 30 patients weren't properly balanced: the sham acupuncture group started out with more severe symptoms according to their own scoring metric, andFigure 2in the paper makes it pretty clear that there was no genuine difference in the effects of real versus sham acupuncture.
But they got it published (in a mediocre journal), so now they point to it as "proof" that acupuncture works for cancer patients. This study, bad as it is, appears to be the basis of the $3.7 million NIH grant that they're now going to use, they say, in "a larger study in 300 patients to confirm these previous findings."
And there you go: the goal of the new study,according to the scientists themselves, is not to see if the treatment works, but to confirm their pre-existing belief that acupuncture works. Or, asone scientist remarked on Twitter, "they already have a result in mind, the whole wording of this suggests that they EXPECT a positive outcome. How did this get funded exactly?"
So I'm mad. I'm mad that NIH is spending millions of dollars on yet another study of a quack treatment (acupuncture) that should have been abandoned decades ago, but that persists because people make money off it. (And, as others have explained in detail, acupuncture is actually a huge scam that former Chinese dictator Mao Zedong foisted on his own people, because he couldn't afford to offer them real medicine. For a good expos of Chairman Mao's scam,see this 2013 Slate piece.)
But I'm even more upset that doctors at one of the world's leading cancer centers are telling desperately ill patients, who trust them with their lives, that sticking needles into their bodies at bogus "acupuncture points" will relieve the pain and nausea of chemotherapy, or help them with other symptoms of cancer. I'm willing to bet that most MSK doctors don't believe any of this, but they don't want to invest the time or energy to try to stop it.
(I am somewhat reassured by the fact that MSK'sTwitter accounthas nearly 75,000 followers, while it's integrative medicine Twitter account has just 110.)
Or perhaps they are "shruggies": doctors who don't believe in nonsense, but figure it's probably harmless so they don't really object. To them I suggest this:read Dr. Val Jones's accountof how she too was a shruggie, until she realized that pseudoscience causes real harm.
And finally, let me point tothis study inJAMA Oncologyfrom last year,by doctors from Yale, which looked at the use of so-called complementary therapies among cancer patients. They found that
"Patients who received complementary medicine were more likely to refuse other conventional cancer treatment, and had a higher risk of death than no complementary medicine."
And also seethis 2017 studyfrom the Journal of the National Cancer Institute, which found that patients who used alternative medicine were 2.5 times more likely to die than patients who stuck to modern medical treatments.
That's right,Memorial Sloan-Kettering: patients who use non-traditional therapies are twice as likely to die. Thats why Im mad. This is not okay.
- Pain treatment using human stem cells a success - News - The University of Sydney - January 24th, 2020
- PRP/Stem Cell Treatment Has Both Functional and Cosmetic Benefits - Haute Living - January 24th, 2020
- Daily briefing: First evidence of how stress turns hair grey - Nature.com - January 24th, 2020
- Gene Therapy for Sickle Cell Disease Receives Orphan Drug Designation - Monthly Prescribing Reference - January 24th, 2020
- High-Definition View of Diabetes-Related Proteins Obtained, Opening the Door to Future Treatments - SciTechDaily - January 24th, 2020
- Cynata Therapeutics to talk stem cell therapies at Proactive"s CEO Sessions - Proactive Investors Australia - January 24th, 2020
- Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of... - January 22nd, 2020
- Stem cell treatment off the table - Zululand Observer - January 22nd, 2020
- UK biotech PhoreMost to work with Otsuka on gene therapy projects - - pharmaphorum - January 22nd, 2020
- J&J wins another label expansion for Darzalex in Europe - PMLiVE - January 22nd, 2020
- Mayo woman raising funds for niece, 4, who is losing her sight from three different eye conditions - Extra.ie - January 22nd, 2020
- Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Predicted to Grow by 2028 with Competitive Situation and Business... - January 22nd, 2020
- Michael Schumacher health update: Neurosurgeon claims F1 legend 'nothing like we remember' - Express.co.uk - January 22nd, 2020
- Bone Therapeutics announces 2020 business outlook and reports year-end 2019 cash position - GlobeNewswire - January 22nd, 2020
- Science Talk - Tell me more about telomeres: how 'basic' science can help us treat cancer - The Institute of Cancer Research - January 22nd, 2020
- The Clinical Trial that MS Patients Have Been Waiting For - Multiple Sclerosis News Today - January 19th, 2020
- Global Cell Therapy Technologies Market Industry Analysis And Forecast (2018-2026) Dagoretti News - Dagoretti News - January 19th, 2020
- Libby Clegg health: Dancing On Ice star is registered blind - what is her condition? - Express - January 19th, 2020
- Stem Cell Therapy Market is Anticipated to Attain a Market Value of US$XX by the End of 2017 2025 - Fusion Science Academy - January 19th, 2020
- Zika Virus' Key into Brain Cells ID'd, Leveraged to Block Infection and Kill Cancer Cells - UC San Diego Health - January 17th, 2020
- Koepka Tied for 3rd in Abu Dhabi in Return From Knee Injury - The New York Times - January 17th, 2020
- Giraffe Will Go Through Risky Procedure At Cheyenne Mountain Zoo To Treat Ongoing Health Issues - CBS Denver - January 17th, 2020
- Novel form of cell-free therapy revealed by researchers - Drug Target Review - January 17th, 2020
- Choosing the Best Therapy for Patients with Chronic Lymphocytic Leukemia - Curetoday.com - January 17th, 2020
- Astellas, Adaptimmune to develop CAR-T & TCR T-cell therapies - BSA bureau - January 17th, 2020
- Melton parents of seriously ill little girl appeal for help to treat her - Melton Times - January 17th, 2020
- Study: Mutations in stem cells of young donors can be passed to recipients - STAT - January 15th, 2020
- Landmark Results for CaverStem Procedure Published in Journal of Translational Medicine to Create Paradigm Shift in Treatment of Erectile Dysfunction... - January 15th, 2020
- Actinium Pharmaceuticals Announces Iomab-ACT Program Gene Therapy Collaboration with UC Davis in Ongoing Clinical Trial for Patients with HIV-Related... - January 15th, 2020
- Bluebird Bio taps ex-Celgene exec Heffron to lead its first gene therapy launch - FiercePharma - January 15th, 2020
- Celgene exec jumps to head bluebird bio ops in Europe, where its $1.8M gene therapy Zynteglo is now available - Endpoints News - January 15th, 2020
- Hemogenyx's CAR-T Cells are Effective Against AML in vitro - GuruFocus.com - January 15th, 2020
- Tolero Pharmaceuticals Announces First Patient Dosed in Phase 2 Zella 202 Study of Investigational Agent Alvocidib in Patients with Relapsed or... - January 15th, 2020
- How Exosomes Could Lead To Stroke Recovery - Technology Networks - January 15th, 2020
- Koepka Ready to Get Back to Work After Nearly 3 Months Off - The New York Times - January 14th, 2020
- Astellas teams with Adaptimmune to create CAR-T, TCR therapies - FierceBiotech - January 14th, 2020
- FROM THE LABS: There is a new player in adult bone healing - Baylor College of Medicine News - January 14th, 2020
- Global Stem Cell Market Is Projected to Grow at a CAGR of 11.9% During the Forecast Period - Press Release - Digital Journal - January 14th, 2020
- Allogeneic Stem Cells Market Expected to Grow with a CAGR of 12% Due to New Product Approvals, 2020-2024 - ResearchAndMarkets.com - Business Wire - January 14th, 2020
- Stemline Therapeutics Announces Preliminary 2019 Net Revenues for ELZONRIS (tagraxofusp) and Highlights Commercial and Clinical Growth Drivers -... - January 14th, 2020
- Stem cell agency indirectly boosted by national industry group - Capitol Weekly - January 13th, 2020
- Muscular dystrophy collaboration aims to correct muscle stem cells' DNA - Harvard Office of Technology Development - January 13th, 2020
- AstroRx Increased Ability to Perform Daily Functions in ALS Patients - ALS News Today - January 13th, 2020
- Fate Therapeutics Announces Expansion of FT516 Clinical Investigation and Publication of Preclinical Data in the Journal Blood - Yahoo Finance - January 13th, 2020
- Police Arrest 3 in Illegal Stem Cell Therapy Allegations - Tempo.co English - January 13th, 2020
- Stem Cell Therapy Market Competitive Analysis 2019-2027 - News ZMR - January 13th, 2020
- Editas Medicine and Sandhill Therapeutics, Inc. Announce Collaboration to Develop Engineered Cell Medicines to Treat Cancer | More News | News... - January 13th, 2020
- First ever progressive MS treatment approved for use by NHS in Scotland - The Scotsman - January 13th, 2020
- Stemline Therapeutics Announces Preliminary 2019 Net Revenues for ELZONRIS (tagraxofusp) and Highlights Commercial and Clinical Growth Drivers - Yahoo... - January 13th, 2020
- The potential use of CRISPR to treat disease is gaining momentum - BioNews - January 13th, 2020
- At 16, Shes a Pioneer in the Fight to Cure Sickle Cell Disease - The New York Times - January 12th, 2020
- At 16, shes a pioneer in the fight to cure sickle cell disease at Boston Childrens - Boston.com - January 12th, 2020
- What is Mantle Cell Lymphoma and How Is It Treated? - Dana-Farber Cancer Institute - January 12th, 2020
- Doug Richards remembered - faribaultcountyregister.com | News, Sports, Information on the Blue Earth region - Faribault County Register - January 12th, 2020
- Kadimastem Finishes Treating Second Group of ALS Patients with AstroRx in Phase 1/2a Trial - ALS News Today - January 11th, 2020
- Jasper Therapeutics Announces Expansion of Series A Financing, Bringing Total Corporate Fundraising to More than $50 Million - Business Wire - January 11th, 2020
- Global Stem Cell Therapies Overview Report 2019: The Highs & Lows, Off-The-Shelf Solutions, New Technologies, and Safety, Efficacy & Logistical... - January 11th, 2020
- Q&A: Cancer Death Rates Are Falling Nationally. Here's What's Happening at UVA - University of Virginia - January 11th, 2020
- SVC112 molecule reduces effects of cancer stem cells with little toxicity - Drug Target Review - January 11th, 2020
- Helius Medical Technologies Awarded Pioneer Technology Development AwardBrain Mapping Foundation and Society for Brain Mapping Therapeutics name the... - January 11th, 2020
- ANP Technologies, in Partnership with Fulgent Pharma, Teams with Moffitt Cancer Center to Develop a New Class of Leukemia Therapies - Business Wire - January 11th, 2020
- Orgenesis adds UC Davis to its point-of-care network for developing cell, gene therapy products - Proactive Investors USA & Canada - January 11th, 2020
- Barry reveals the truth about Fiona on Fair City - RTE.ie - January 11th, 2020
- What will be the biggest scientific breakthrough of 2020? - Stuff.co.nz - January 11th, 2020
- Global Stem Cell Therapy Market 2020 by Company, Regions, Type and Application, Forecast to 2025 - BulletintheNews - January 11th, 2020
- Promethera Announces Initiation of Phase 2b DHELIVER Study of HepaStem in Patients with Acute-on-Chronic Liver Failure (ACLF) - Business Wire - January 9th, 2020
- Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture - Technology Networks - January 9th, 2020
- Global Stem Cell Therapy Market Size is anticipated to grow at a strong CAGR by 2025 - Technology Magazine - January 9th, 2020
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To 2026 - ReportsPioneer - January 9th, 2020
- Global Gene Therapy Market is Expected to Reach US$ 5,609.9 Million by 2027, Growing at an Estimated CAGR of 8.2% Over the Forecast Period as... - January 9th, 2020
- CohBar Discovers Novel Peptide Inhibitors of CXCR4, a Key Regulator of Tumor Growth and Metastasis - Associated Press - January 9th, 2020
- Innovative Cellular Therapeutics Appoints Cell and Gene Therapy Manufacturing Expert Christopher Ballas, Ph.D., as SVP of Manufacturing - Yahoo... - January 9th, 2020
- Kevin Nash on How His Health Is After Knee Replacement & Stem Cell Therapy, Why He Retired - LordsofPain.net - January 9th, 2020
- Stem Cell Alopecia Treatment Market 2019 Globally Expected to Drive Growth through 2024 - ReportsPioneer - January 9th, 2020
- Bone Therapeutics announces attendance at the 38th Annual J.P. Morgan Healthcare Conference - GlobeNewswire - January 9th, 2020
- Innovative Cellular Therapeutics Appoints Cell and Gene Therapy Manufacturing Expert Christopher Ballas, Ph.D., as SVP of Manufacturing - BioSpace - January 7th, 2020
- Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR Therapy for Relapsed or Refractory T-cell Malignancies - PRNewswire - January 7th, 2020
- Patrick Reed's latest controversy and the other things in golf that matter right now - ESPN - January 7th, 2020
- Diomics Corporation and University of California, Irvine Collaborate to Enable Cell Therapy Clinical Trial for Type 1 Diabetes - GlobeNewswire - January 7th, 2020
- Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Research Explores The Key Success Factors, And Business Opportunities Including Key... - January 7th, 2020